Cholestech/Abbott
This article was originally published in The Gray Sheet
Executive Summary
Cholestech GDX system will be distributed globally by Abbott to physician offices and hospital-based customers under an agreement signed July 24. GDX, which measures glycated hemoglobin rates, provides an average glucose level from the previous 90 days and offers an immediate risk assessment of diabetes. For the first quarter ended June 28, Cholestech sales were off 6% to $11.6 mil., while earnings rose 13% to $1.4 mil...